高级检索
    常建华, 高红飞. MET 基因扩增的肺癌细胞系依赖MET生长和生存[J]. 循证医学, 2014, 14(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2014.04.009
    引用本文: 常建华, 高红飞. MET 基因扩增的肺癌细胞系依赖MET生长和生存[J]. 循证医学, 2014, 14(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2014.04.009
    shu
    CHANG Jian-hua, GAO Hong-fei. Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on MET for Growth and Survival[J]. Journal of Evidence-Based Medicine, 2014, 14(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2014.04.009
    Citation: CHANG Jian-hua, GAO Hong-fei. Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on MET for Growth and Survival[J]. Journal of Evidence-Based Medicine, 2014, 14(4): 213-215. DOI: 10.3969/j.issn.1671-5144.2014.04.009
    shu

    MET 基因扩增的肺癌细胞系依赖MET生长和生存

    Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on MET for Growth and Survival

      摘要
    • 摘要: 近年来,分子靶向治疗在NSCLC中开创了新的治疗方式,尤其是EGFR-TKI及ALK抑制剂在晚期NSCLC患者中显示出明显的生存获益,诸如HGF/MET信号传导通路的研究显示可能为NSCLC提供新的治疗靶点。

       

      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回